Artwork

Content provided by Best Podcasts Similar Masters Of Scale - 3 Episodes per week. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Best Podcasts Similar Masters Of Scale - 3 Episodes per week or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

a16z: a16z Podcast: Revisiting the Gene

 
Share
 

Archived series ("HTTP Redirect" status)

Replaced by: Masters Of Scale.

When? This feed was archived on March 13, 2018 00:23 (6y ago). Last successful fetch was on March 12, 2018 09:39 (6y ago)

Why? HTTP Redirect status. The feed permanently redirected to another series.

What now? If you were subscribed to this series when it was replaced, you will now be subscribed to the replacement series. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.

Manage episode 199721306 series 2102268
Content provided by Best Podcasts Similar Masters Of Scale - 3 Episodes per week. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Best Podcasts Similar Masters Of Scale - 3 Episodes per week or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Published on 10 Jan 2018. The complete sequencing of the human genome is one of the most powerful examples of technology and science in action: We've gone from needing $3 billion and over 13 years to read a single human genome to today, to where we can do that same amount of work for about $1,000 in roughly 2 days -- and the price will only continue to drop. But beyond pricing, what does understanding the gene -- and moving from the sequencing layer to the applications layer -- mean to us; what new questions arise now that we can sequence DNA quickly, reliably, and cheaply? This conversation -- with co-founder and CEO of Jungla Carlos Araya and co-founder and CEO of Freenome Gabe Otte, moderated by a16z General Partner Jorge Conde (based on a discussion that took place at a16z’s annual Summit in November 2017) -- takes a step back and considers all these questions. Every time a human genome sequence is completed, there are on the order of 3,000,000 new variants identified. So how do we think about interpreting all that data? Actionability? And how do we derive meaning from all this, for applications in the clinical space?
  continue reading

73 episodes

Artwork
iconShare
 

Archived series ("HTTP Redirect" status)

Replaced by: Masters Of Scale.

When? This feed was archived on March 13, 2018 00:23 (6y ago). Last successful fetch was on March 12, 2018 09:39 (6y ago)

Why? HTTP Redirect status. The feed permanently redirected to another series.

What now? If you were subscribed to this series when it was replaced, you will now be subscribed to the replacement series. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.

Manage episode 199721306 series 2102268
Content provided by Best Podcasts Similar Masters Of Scale - 3 Episodes per week. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Best Podcasts Similar Masters Of Scale - 3 Episodes per week or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Published on 10 Jan 2018. The complete sequencing of the human genome is one of the most powerful examples of technology and science in action: We've gone from needing $3 billion and over 13 years to read a single human genome to today, to where we can do that same amount of work for about $1,000 in roughly 2 days -- and the price will only continue to drop. But beyond pricing, what does understanding the gene -- and moving from the sequencing layer to the applications layer -- mean to us; what new questions arise now that we can sequence DNA quickly, reliably, and cheaply? This conversation -- with co-founder and CEO of Jungla Carlos Araya and co-founder and CEO of Freenome Gabe Otte, moderated by a16z General Partner Jorge Conde (based on a discussion that took place at a16z’s annual Summit in November 2017) -- takes a step back and considers all these questions. Every time a human genome sequence is completed, there are on the order of 3,000,000 new variants identified. So how do we think about interpreting all that data? Actionability? And how do we derive meaning from all this, for applications in the clinical space?
  continue reading

73 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide